EvAluation of the efficacy of MaaT013 as salvage theRapy in acute GVHD patiEntS with gastrointestinal involvement, refractory to ruxolitinib; a multi-center open-label phase III trial.

Ohrakupressur bei Patienten mit Multiplem Myelom - eine randomisierte kontrollierte Studie

A Multi-National Prospective non interventional study of standard of care in participants with MM who are refractory to at least one Proteasome inhibitor, one immunmodulatory  Drug and one anti-CD38 antibody

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

A Phase 3 Randomized Study Comparing Teclistamab in Combination with Daratumumab SC and Lenalidomide (Tec-DR) and Talquetamab in Combination with Daratumumab SC and Lenalidomide (Tal-DR) versus Daratumumab SC, Lenalidomide, and Dexamethasone (DRd) in Participants with Newly Diagnosed Multiple Myeloma Who are Either Ineligible or not Intended for Autologous Stem Cell Transplant as Initial Therapy 

Genetische Veränderungen, Therapieansprechen und Resistenzentwicklung beim Melanom

Machbarkeitsstudie zu Einfluss des intestinalen Mikrobioms auf die Anastomosenheilung nach chirurgischer Resektion beim Rektumkarzinom

Abemaciclib and endocrine therapy in hormone receptor positive HER2 negative locally advanced or metastatic breast cancer with focos on digital side effect management